BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 11845326)

  • 1. Over-expression of the glucagon-like peptide-1 receptor on INS-1 cells confers autocrine stimulation of insulin gene promoter activity: a strategy for production of pancreatic beta-cell lines for use in transplantation.
    Chepurny OG; Holz GG
    Cell Tissue Res; 2002 Feb; 307(2):191-201. PubMed ID: 11845326
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide 1 stimulates insulin gene promoter activity by protein kinase A-independent activation of the rat insulin I gene cAMP response element.
    Skoglund G; Hussain MA; Holz GG
    Diabetes; 2000 Jul; 49(7):1156-64. PubMed ID: 10909973
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Exendin-4 as a stimulator of rat insulin I gene promoter activity via bZIP/CRE interactions sensitive to serine/threonine protein kinase inhibitor Ro 31-8220.
    Chepurny OG; Hussain MA; Holz GG
    Endocrinology; 2002 Jun; 143(6):2303-13. PubMed ID: 12021195
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucagon-like peptide-1 stimulates human insulin promoter activity in part through cAMP-responsive elements that lie upstream and downstream of the transcription start site.
    Hay CW; Sinclair EM; Bermano G; Durward E; Tadayyon M; Docherty K
    J Endocrinol; 2005 Aug; 186(2):353-65. PubMed ID: 16079261
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Engineered beta-cells secreting dipeptidyl peptidase IV-resistant glucagon-like peptide-1 show enhanced glucose-responsiveness.
    Islam MS; Rahman SA; Mirzaei Z; Islam KB
    Life Sci; 2005 Jan; 76(11):1239-48. PubMed ID: 15642594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection of pancreatic-derived beta-cells with a minigene encoding for human glucagon-like peptide-1 regulates glucose-dependent insulin synthesis and secretion.
    Hui H; Yu R; Bousquet C; Perfetti R
    Endocrinology; 2002 Sep; 143(9):3529-39. PubMed ID: 12193567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Glucagon-like peptide-1 improves insulin and proinsulin binding on RINm5F cells and human monocytes.
    Ebinger M; Jehle DR; Fussgaenger RD; Fehmann HC; Jehle PM
    Am J Physiol Endocrinol Metab; 2000 Jul; 279(1):E88-94. PubMed ID: 10893327
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Insulinotropic hormone glucagon-like peptide 1 (GLP-1) activation of insulin gene promoter inhibited by p38 mitogen-activated protein kinase.
    Kemp DM; Habener JF
    Endocrinology; 2001 Mar; 142(3):1179-87. PubMed ID: 11181533
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of glucagon receptors on hormone-specific endocrine cells of rat pancreatic islets.
    Kieffer TJ; Heller RS; Unson CG; Weir GC; Habener JF
    Endocrinology; 1996 Nov; 137(11):5119-25. PubMed ID: 8895386
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NFAT regulates insulin gene promoter activity in response to synergistic pathways induced by glucose and glucagon-like peptide-1.
    Lawrence MC; Bhatt HS; Easom RA
    Diabetes; 2002 Mar; 51(3):691-8. PubMed ID: 11872668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Signal transduction by the cloned glucagon-like peptide-1 receptor: comparison with signaling by the endogenous receptors of beta cell lines.
    Widmann C; Bürki E; Dolci W; Thorens B
    Mol Pharmacol; 1994 May; 45(5):1029-35. PubMed ID: 8190093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Exendin-4 is a high potency agonist and truncated exendin-(9-39)-amide an antagonist at the glucagon-like peptide 1-(7-36)-amide receptor of insulin-secreting beta-cells.
    Göke R; Fehmann HC; Linn T; Schmidt H; Krause M; Eng J; Göke B
    J Biol Chem; 1993 Sep; 268(26):19650-5. PubMed ID: 8396143
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exendin-(9-39) is an inverse agonist of the murine glucagon-like peptide-1 receptor: implications for basal intracellular cyclic adenosine 3',5'-monophosphate levels and beta-cell glucose competence.
    Serre V; Dolci W; Schaerer E; Scrocchi L; Drucker D; Efrat S; Thorens B
    Endocrinology; 1998 Nov; 139(11):4448-54. PubMed ID: 9794451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glucagon-like peptide-1 promotes DNA synthesis, activates phosphatidylinositol 3-kinase and increases transcription factor pancreatic and duodenal homeobox gene 1 (PDX-1) DNA binding activity in beta (INS-1)-cells.
    Buteau J; Roduit R; Susini S; Prentki M
    Diabetologia; 1999 Jul; 42(7):856-64. PubMed ID: 10440129
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Desensitization and phosphorylation of the glucagon-like peptide-1 (GLP-1) receptor by GLP-1 and 4-phorbol 12-myristate 13-acetate.
    Widmann C; Dolci W; Thorens B
    Mol Endocrinol; 1996 Jan; 10(1):62-75. PubMed ID: 8838146
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Basal receptor activation by locally produced glucagon-like peptide-1 contributes to maintaining beta-cell function.
    Masur K; Tibaduiza EC; Chen C; Ligon B; Beinborn M
    Mol Endocrinol; 2005 May; 19(5):1373-82. PubMed ID: 15677711
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutations to the third cytoplasmic domain of the glucagon-like peptide 1 (GLP-1) receptor can functionally uncouple GLP-1-stimulated insulin secretion in HIT-T15 cells.
    Salapatek AM; MacDonald PE; Gaisano HY; Wheeler MB
    Mol Endocrinol; 1999 Aug; 13(8):1305-17. PubMed ID: 10446905
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cell signalling of glucagon-like peptide-1 action in rat skeletal muscle.
    Acitores A; González N; Sancho V; Valverde I; Villanueva-Peñacarrillo ML
    J Endocrinol; 2004 Mar; 180(3):389-98. PubMed ID: 15012593
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Synergistic effect of dimethyl sulfoxide on glucagon-like peptide 1 (GLP-1)-stimulated insulin secretion and gene transcription in INS-1 cells: characterization and implications.
    Kemp DM; Habener JF
    Biochem Pharmacol; 2002 Aug; 64(4):689-97. PubMed ID: 12167488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.